
The Society
More than 35,000 clinicians, scientists and allied health professionals from over 160 countries are part of the ERS community
Become an ERS member

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.
Other cookies are those that are being identified and have not been classified into any category as yet.
The Executive Committee both manages and represents ERS by directing and conducting the general activities of the Society on behalf of the General Assembly. The Executive Committee provides an annual report on all activities to the General Assembly.
None
Company | Purpose of Payment | Amount of funds received* |
---|---|---|
Irish Rugby Football Union | Ad hoc Consultancy work | A |
American College of Cardiology | Content Development | B |
None
None
Company | Nature of Support | Amount of funds received* |
---|---|---|
NovoNordisk | Unrestricted grant | D |
Fitbit | Unrestricted grant | D |
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
A | B | C | D |
---|---|---|---|
less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
None
Company | Purpose of Payment | Amount of funds received* |
---|---|---|
Nestle | Lecture fee and Advisory board | B |
Sanofi-Regeneron | AdBoard, Lecture fee | B |
ALK | Lecture fee, Ad Board | B |
AstraZeneca | AdBoard, Lecture fee | B |
OMPharma | AdBoard | B |
None
None
Company | Nature of Support | Amount of funds received* |
---|---|---|
OM Pharma | Clinical Study fees | C |
DBV | Clinical Study fees | C |
ALK | Clinical Study fees | B |
Sanofi | Clinical Study fees | C |
AstraZeneca | Clinical Study fees | B |
Infectopharm | Clinical Study fees | C |
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
A | B | C | D |
---|---|---|---|
less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
None
Company | Purpose of Payment | Amount of funds received* |
---|---|---|
CSL Behring | lectures | B |
Grifols | jury of the "Annual ALTA (Alpha-1-Antitrypsin Laurell’s Training Awards) 2025" | B |
Sanofi | lectures, advisory board | B |
Amgen | lectures, congress participation | B |
Chiesi | lectures, congress participation | B |
Pfizer | lectures | B |
Amgen | lectures | B |
Chiesi | lectures | B |
Company | Purpose and Nature of Benefit | Amount of funds received* |
---|---|---|
Chiesi | travel grant | B |
Amgen | travel grant | B |
None
None
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
A | B | C | D |
---|---|---|---|
less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
None
None
None
None
None
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
A | B | C | D |
---|---|---|---|
less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
Company | Area | Product | Amount of funds received* |
---|---|---|---|
INOGEN | Oxygen therapy | questionnaire development | B |
None
None
None
Company | Nature of Support | Amount of funds received* |
---|---|---|
RESMED | grant for studies | D |
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
A | B | C | D |
---|---|---|---|
less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
None
Company | Purpose of Payment | Amount of funds received* |
---|---|---|
TEVA pharmaceuticals | Honorarium for a non-promotional talk in a sponsored symposium at the ERS2022 | B |
Sandoz pharmaceuticals | Honorarium for a non-promotional talk in a sponsored symposium at the PCRS 2022 | B |
None
None
None
Company or organisation | Nature/Purpose of Support |
---|---|
International Primary Care Respiratory Group | Professional Society (multi-sponsorship from Industry) |
Primary Care Respiratory Society | Professional Society (multi-sponsorship from Industry) |
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
A | B | C | D |
---|---|---|---|
less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
None
Company | Purpose of Payment | Amount of funds received* |
---|---|---|
AstraZeneca | Presentations, advisory boards | C |
GSK | Presentations, advisory boards | C |
Chiesi | Presentations, advisory boards | C |
Sanofi | Presentations, advisory boards | C |
Roche | Consultation | B |
Ménarini | Presentation | A |
Pfizer | Consultation | B |
Boehringer Ingelheim | Education | A |
Company | Purpose and Nature of Benefit | Amount of funds received* |
---|---|---|
Sanofi | French Respiratory Society Congress | A |
None
Company | Nature of Support | Amount of funds received* |
---|---|---|
GSK | Research grant | C |
Pfizer | Research grant | C |
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
A | B | C | D |
---|---|---|---|
less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
None
Company | Purpose of Payment | Amount of funds received* |
---|---|---|
various universities | Reviews, PhD defences | A |
various teaching institutions | lectures outside my home university | A |
Company | Purpose and Nature of Benefit | Amount of funds received* |
---|---|---|
ERS | various conferences in my function as advocacy chair | C |
None
Company | Nature of Support | Amount of funds received* |
---|---|---|
DFG | Research grant | D |
BMBF | Research grant | D |
German Environment Agency | Research grant | D |
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
A | B | C | D |
---|---|---|---|
less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
None
None
None
None
None
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
A | B | C | D |
---|---|---|---|
less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
All ERS Assembly Heads are also members of the Executive Committee.